Teens with treatment-resistant depression more likely to improve with combination therapy

User rating: not rated yet

Teens with difficult-to-treat depression who do not respond to a first antidepressant medication are more likely to get well if they switch to another antidepressant medication and add psychotherapy rather than just switching to another antidepressant, according to a large, multi-site trial funded by the National Institutes of Health’s National Institute of Mental Health (NIMH). The results of the Treatment of SSRI-resistant Depression in Adolescents (TORDIA) trial were published February 27, 2008, in the Journal of the American Medical Association.


Full story »

All News summaries from Medicine & Health news
All News summaries for February 26, 2008

Briton fuming over fine for smoking in own van

6 hours ago | User rating: not rated yet
A painter and decorator has been fined for breaching Britain's smoking ban -- by puffing on a cigarette in his own van, he said Friday.

Surgical Instrument Size Studied

6 hours ago | User rating: not rated yet
The concept of one size fits all works with many things—smocks, baseball caps and inner tubes. But not disposable laparoscopic surgical instruments.

Hip Bone Density Helps Predict Breast Cancer Risk

6 hours ago | User rating: not rated yet
Measuring a woman’s bone mineral density can provide additional information that may help more accurately determine a woman’s risk of developing breast cancer. That is the conclusion of a new study published in the September ...

Overweight elderly Americans contribute to financial burdens of the US health care system

7 hours ago | User rating: not rated yet
Being overweight or obese is not only a personal issue that affects one's health but is also a public health issue that impacts other people in society. A new study in the journal Health Services Research reveals that ...

'Lazy eye' discovery of how an old gene learns new tricks

7 hours ago | User rating: not rated yet
(PhysOrg.com) -- Researchers have made a discovery which could lead the way for new treatments into a rare eye disorder which if not treated can result in permanent blindness in childhood.